Changes in mRNA expression of Caspase-3, ALDH2, Bcl-2, Bax and Bcl-2/Bax in three groups. by Qingqing Hao (5464070)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Percentages (%) of concentration changes in TNF-α, IL-6, and IFN-γ released by PANC-1 cells under hypoxic and normoxic conditions cultured with CD8+ T-cells CM. by Eiman Abdo (20642254)

Subjects:

Graphical presentation of % decrease for insulin from baseline at different conditions. by Nathan Mubiru (21627195)

HFD decreases ITM and alters metabolic homeostasis. by Tong Yue (6033305)

“…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …”

Shuffling identity decreases behavior trajectory uniqueness. by Catalin Mitelut (5587493)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Effectiveness of the proposed method to decrease chloroplast contamination. by Gabriela Madrid (11871401)

Percentage change in the apparent density of pristine and modified Egyptian kaolin sintered at 1050 °C for 4 successive cycles. by Nasser A. M. Barakat (11705885)

Subjects:

Sudden change from skewed distributions. by Ariel Burman (20329776)

Subjects:

Time and spatial sensitivity to process changes. by Ariel Burman (20329776)

Subjects:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects:

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects:

General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

Subjects: